Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  gadopentetate dimeglumine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Multihance Versus Magnevist in Breast MRI
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MH 131, NCT00486473
Gadobutrol Magnevist-controlled Body Study
Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 13297, NCT01050829
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069496, ACRIN 6657, CALGB-150012, NCT00043017
MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000067622, ACRIN-6651, GOG-183, CA80098, NCT00004936
Pilot Diagnostic Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Children or Adults Who Receive Neurotoxic Therapy for Cancer
Phase: No phase specified
Type: Diagnostic
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-99-C-0088, NCT00020293
Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069280, CALGB-150007, NCT00033397
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000285698, ACRIN-6667, NCT00058058
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: J06108, NA_00003943, NCT00539253
Start Over